0,846  0,005  Antileukemic
0,846  0,010  Antiinflammatory
0,827  0,007  Antineoplastic (breast cancer)
0,823  0,014  Apoptosis agonist
0,797  0,004  Cardiovascular analeptic
0,799  0,007  Antineoplastic (colorectal cancer)
0,798  0,007  Antineoplastic (colon cancer)
0,765  0,004  Antineoplastic (multiple myeloma)
0,765  0,011  Antineoplastic (lung cancer)
0,742  0,005  Antineoplastic (glioma)
0,727  0,005  Antineoplastic (melanoma)
0,725  0,008  Antineoplastic (ovarian cancer)
0,709  0,009  Prostate cancer treatment
0,704  0,005  Nitric oxide antagonist
0,702  0,005  Immunosuppressant
0,698  0,005  Antineoplastic (brain cancer)
0,683  0,005  Antimitotic
0,679  0,005  Antineoplastic (glioblastoma multiforme)
0,674  0,012  Respiratory analeptic
0,646  0,005  Antiprotozoal (Leishmania)
0,628  0,015  Antiprotozoal
0,611  0,004  Antiviral (Influenza)
0,612  0,010  Antineoplastic (pancreatic cancer)
0,613  0,030  Transcription factor NF kappa B inhibitor
0,585  0,015  Analeptic
0,549  0,003  T cell inhibitor
0,536  0,019  Antineoplastic (cervical cancer)
0,530  0,033  Antibacterial
0,485  0,005  Antiviral (Influenza A)
0,481  0,003  Chymotrypsin inhibitor
0,499  0,033  Antipruritic, allergic
0,475  0,012  Antineoplastic (renal cancer)
0,458  0,025  Cytostatic
0,457  0,036  Antithrombotic
0,427  0,018  Vascular (periferal) disease treatment
0,405  0,007  Interleukin 6 antagonist
0,413  0,017  Antineoplastic (lymphocytic leukemia)
0,425  0,034  AR expression inhibitor
0,395  0,005  Antifungal enhancer
0,399  0,012  Platelet adhesion inhibitor
0,410  0,025  Tumour necrosis factor alpha release inhibitor
0,398  0,015  UGT1A4 substrate
0,387  0,010  Antialcoholic
0,396  0,024  Antineoplastic (liver cancer)
0,403  0,032  Antineoplastic (non-small cell lung cancer)
0,416  0,046  Cholesterol antagonist
0,387  0,018  Abortion inducer
0,420  0,057  CYP3A4 substrate
0,389  0,026  Antiparasitic
0,389  0,043  Antimycobacterial
0,353  0,015  Diabetic retinopathy treatment
0,352  0,015  Antipruritic, non-allergic
0,380  0,044  Lipoprotein disorders treatment
0,340  0,004  Kallikrein 1 inhibitor
0,375  0,042  Metabolic disease treatment
0,338  0,016  Antiviral (Hepatitis)
0,331  0,013  Protein kinase stimulant
0,341  0,026  GST M1-1 substrate
0,392  0,080  TNF expression inhibitor
0,345  0,035  Chemopreventive
0,361  0,057  Antifungal
0,360  0,057  ICAM1 expression inhibitor
0,309  0,015  Diabetic nephropathy treatment
0,304  0,014  Antiviral (Hepatitis C)
0,369  0,079  GST A substrate
0,398  0,112  Caspase 9 stimulant
0,291  0,012  UGT2B9 substrate
0,320  0,043  Hypolipemic
0,318  0,051  NOS2 expression inhibitor
0,312  0,047  Antineoplastic (lymphoma)
0,346  0,085  Ulceration
0,310  0,049  Proliferative diseases treatment
0,292  0,033  Antihelmintic
0,262  0,005  Growth stimulant
0,276  0,021  UGT2B15 substrate
0,333  0,078  Angiogenesis inhibitor
0,309  0,058  UGT2B4 substrate
0,260  0,010  Farnesoid X receptor antagonist
0,287  0,040  Antiparkinsonian, rigidity relieving
0,251  0,005  Arachidonic acid antagonist
0,273  0,027  Neurotrophic factor enhancer
0,253  0,008  Microtubule formation inhibitor
0,319  0,074  Calcium channel activator
0,262  0,022  Allergic rhinitis treatment
0,251  0,015  Proteasome inhibitor
0,291  0,058  Sensitization
0,285  0,054  Cytotoxic
0,238  0,011  Antirickettsial
0,254  0,029  Antiacne
0,254  0,030  Contraceptive
0,254  0,032  Lipocortins synthesis antagonist
0,269  0,051  Carcinogenic
0,285  0,067  Antioxidant
0,303  0,085  FMO1 substrate
0,231  0,014  Nav1.1 sodium channel blocker
0,256  0,039  UGT2B7 substrate
0,232  0,016  Antineoplastic antibiotic
0,241  0,030  Interferon gamma antagonist
0,271  0,061  Cardiodepressant
0,285  0,075  5 Hydroxytryptamine release stimulant
0,216  0,008  Aromatase inhibitor
0,270  0,063  5 Hydroxytryptamine uptake stimulant
0,294  0,089  Apoptosis antagonist
0,226  0,021  DNA polymerase I inhibitor
0,204  0,002  Antitreponemal
0,249  0,049  UDP-glucuronosyltransferase substrate
0,203  0,012  Adenylate cyclase stimulant
0,236  0,047  Growth hormone agonist
0,284  0,097  Antineoplastic (small cell lung cancer)
0,219  0,032  Skin irritative effect
0,245  0,059  Antihypotensive
0,221  0,039  Antiviral (Herpes)
0,183  0,006  Ca2+-transporting ATPase inhibitor
0,251  0,076  Teratogen
0,226  0,053  Pneumotoxic
0,335  0,168  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,168  0,001  Tubulin agonist
0,210  0,044  Acaricide
0,182  0,018  Contraceptive female
0,201  0,040  Melanin inhibitor
0,223  0,065  VCAM1 expression inhibitor
0,323  0,165  Antineoplastic (solid tumors)
0,235  0,078  DNA synthesis inhibitor
0,249  0,092  Spasmolytic
0,166  0,011  GST T1-1 substrate
0,178  0,025  Beta amyloid protein antagonist
0,171  0,018  Cathepsin G inhibitor
0,239  0,088  Chronic obstructive pulmonary disease treatment
0,229  0,079  Embryotoxic
0,178  0,028  Antismoking
0,212  0,065  UGT1A1 substrate
0,207  0,061  Hepatoprotectant
0,190  0,045  Antineoplastic (squamous cell carcinoma)
0,220  0,075  Antiulcerative
0,189  0,046  UGT2B10 substrate
0,230  0,087  Antidiabetic symptomatic
0,151  0,011  Thrombin inhibitor
0,197  0,058  Muscle relaxant
0,152  0,020  Actinic keratosis treatment
0,181  0,050  Antiparkinsonian, tremor relieving
0,139  0,013  Epoxide hydrolase inhibitor
0,203  0,078  Psychostimulant
0,224  0,101  UGT1A9 substrate
0,129  0,008  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,157  0,036  Carcinogenic, group 2B
0,176  0,056  Uterine stimulant
0,162  0,043  Antieczematic
0,121  0,003  Lipocortins synthesis agonist
0,173  0,056  Antineoplastic (carcinoma)
0,130  0,013  Nicotinic alpha4beta2 receptor antagonist
0,119  0,003  Microtubule stabilization
0,291  0,175  5 Hydroxytryptamine release inhibitor
0,135  0,023  UGT2B11 substrate
0,253  0,145  Antineoplastic (endocrine cancer)
0,135  0,027  Anabolic
0,170  0,065  Eye irritation, high
0,227  0,122  Hypoxia-inducible factor 1 alpha inhibitor
0,121  0,016  Na+ K+ transporting ATPase inhibitor
0,146  0,042  Glutathione S-transferase substrate
0,108  0,006  Factor VII inhibitor
0,124  0,023  Ornithine decarboxylase inhibitor
0,153  0,053  Alpha-N-acetylglucosaminidase inhibitor
0,181  0,082  Sedative
0,128  0,030  Androgen antagonist
0,126  0,029  Antispirochetal
0,157  0,060  Antiprotozoal (Coccidial)
0,099  0,004  CXC chemokine 3 receptor antagonist
0,123  0,029  Acetylcholine nicotinic antagonist
0,138  0,044  Rhinitis treatment
0,149  0,055  Pregnane X receptor agonist
0,114  0,022  Glycine receptor antagonist
0,103  0,012  Antimycoplasmal
0,164  0,073  UGT1A3 substrate
0,181  0,091  VEGF expression inhibitor
0,095  0,006  HCV NS3/NS4A protease inhibitor
0,152  0,063  Skeletal muscle relaxant
0,116  0,028  Antibiotic
0,169  0,082  Succinate dehydrogenase inhibitor
0,194  0,108  Antihypercholesterolemic
0,217  0,132  NOS3 expression inhibitor
0,223  0,140  CTGF expression inhibitor
0,096  0,014  Protein 50S ribosomal subunit inhibitor
0,188  0,108  Antiamyloidogenic
0,114  0,035  Paget's disease treatment
0,163  0,085  Toxic, respiratory center
0,086  0,008  Anesthetic inhalation
0,097  0,022  Prokinetic
0,179  0,105  Angiogenesis stimulant
0,093  0,020  Trypsin inhibitor
0,079  0,008  Adenylate cyclase 1 inhibitor
0,081  0,010  Prolyl endopeptidase inhibitor
0,094  0,024  Glycine receptor agonist
0,080  0,011  Acetyl-CoA transferase 2 inhibitor
0,197  0,131  Antineoplastic (sarcoma)
0,155  0,089  Antipruritic
0,078  0,013  Leukocyte elastase inhibitor
0,084  0,020  SULT2A1 substrate
0,104  0,041  Antidote, mercury
0,149  0,086  Mutagenic
0,108  0,046  Tourette's syndrome treatment
0,075  0,013  Oxytocin antagonist
0,138  0,079  SULT1A3 substrate
0,086  0,027  Anticholelithogenic
0,091  0,033  Narcotic antagonist
0,063  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,081  0,023  Glutamate (mGluR6) antagonist
0,195  0,138  CYP2C19 substrate
0,152  0,098  ATPase inhibitor
0,113  0,060  GABA C receptor antagonist
0,085  0,032  Neuronal nicotinic receptor antagonist
0,073  0,020  Elastase inhibitor
0,200  0,149  Gastrin inhibitor
0,071  0,020  Postcoital contraceptive
0,217  0,166  Vasodilator, coronary
0,127  0,076  Nav1.2 sodium channel blocker
0,054  0,004  Glucocorticoid agonist
0,071  0,022  Peristaltic stimulant
0,058  0,011  Arginase inhibitor
0,107  0,060  Antiviral (Poxvirus)
0,115  0,070  Cholesterol synthesis inhibitor
0,084  0,039  Phosphofructokinase-1 inhibitor
0,190  0,146  Chemoprotective
0,047  0,003  Corticosteroid-like
0,118  0,076  Nav1.3 sodium channel blocker
0,050  0,008  Vanilloid 3 antagonist
0,098  0,056  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,180  0,139  Antiprotozoal (Trypanosoma)
0,052  0,011  Trypsin I inhibitor
0,149  0,108  Phospholipase C inhibitor
0,066  0,026  Acetyl-CoA transferase inhibitor
0,082  0,044  Antidote, organophosphates
0,177  0,139  RNA-directed DNA polymerase inhibitor
0,102  0,064  Protease inhibitor
0,097  0,059  Prolactin inhibitor
0,108  0,072  Interleukin 1b antagonist
0,192  0,156  Antipsoriatic
0,087  0,050  Antiprotozoal activity enhancer
0,115  0,079  Antiviral (Influenza B)
0,233  0,198  Antineoplastic (myeloid leukemia)
0,059  0,025  Vanilloid 2 antagonist
0,042  0,009  Vasopressin 1B antagonist
0,148  0,119  P-glycoprotein inhibitor
0,060  0,031  Pregnane X receptor antagonist
0,105  0,077  Interleukin 2 antagonist
0,163  0,136  UGT1A6 substrate
0,089  0,062  Potassium channel activator
0,187  0,161  Tyrosine 3 hydroxylase inhibitor
0,102  0,077  Electron transport complex I inhibitor
0,085  0,060  Antineoplastic alkaloid
0,028  0,004  Telomerase stimulant
0,132  0,109  Heat shock protein 70 antagonist
0,134  0,113  Carcinogenic, group 1
0,144  0,123  Non-steroidal antiinflammatory agent
0,050  0,029  Aldosterone antagonist
0,031  0,011  Nicotinic acid receptor 2 antagonist
0,054  0,035  Alpha-mannosidase inhibitor
0,059  0,041  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,119  0,101  Pancreatic disorders treatment
0,059  0,042  Androgen agonist
0,055  0,038  Bombesin 3 receptor antagonist
0,103  0,087  Antiviral (CMV)
0,166  0,150  5 Hydroxytryptamine 3E antagonist
0,109  0,096  Antifungal (Pneumocystis)
0,167  0,154  Peptidyltransferase inhibitor
0,107  0,094  Anesthetic
0,063  0,051  Uterine relaxant
0,090  0,079  GABA C receptor agonist
0,088  0,077  UDP-glucose 4-epimerase inhibitor
0,090  0,081  Expectorant
0,051  0,041  Nicotinic alpha3beta2 receptor antagonist
0,032  0,023  Glucocorticoid antagonist
0,020  0,011  Progesterone agonist
0,129  0,120  CF transmembrane conductance regulator agonist
0,051  0,043  Postmenopausal disorders treatment
0,082  0,074  Tocolytic
0,068  0,060  Glutamate dehydrogenase inhibitor
0,032  0,024  Vasopressin 2 antagonist
0,076  0,069  Inducible nitric-oxide synthase inhibitor
0,101  0,094  Cholinergic antagonist
0,040  0,034  Guanylate cyclase inhibitor
0,030  0,025  ATP citrate lysase inhibitor
0,054  0,049  Carbamoyl phosphate synthetase inhibitor
0,099  0,094  Acetylcholine antagonist
0,070  0,066  Keratolytic
0,093  0,090  SULT1A1 substrate
0,076  0,075  GST P1-1 substrate
0,015  0,014  Vitamin D receptor agonist
0,038  0,037  Kainate receptor agonist
0,144  0,142  Insulin sensitizer
0,026  0,025  Hedgehog signaling activator
0,025  0,024  RNA-directed RNA polymerase stimulant
0,048  0,048  Nicotinic receptor alpha7 subunit antagonist

